164 related articles for article (PubMed ID: 36660706)
1. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
Ma M; Xu S; Han B; He H; Ma X; Chen C
Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
Yue YS; Sun ZH; Cui Q; Jiang GZ
Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
[TBL] [Abstract][Full Text] [Related]
3. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
4. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
5. Artificial-intelligence-based computed tomography histogram analysis predicting tumor invasiveness of lung adenocarcinomas manifesting as radiological part-solid nodules.
Gao J; Qi Q; Li H; Wang Z; Sun Z; Cheng S; Yu J; Zeng Y; Hong N; Wang D; Wang H; Yang F; Li X; Li Y
Front Oncol; 2023; 13():1096453. PubMed ID: 36910632
[TBL] [Abstract][Full Text] [Related]
6. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of postoperative folate receptor-positive circulating tumor cells (FR + CTCs) for long-term prognosis in patients with invasive adenocarcinoma (IAC) of the lung.
Ma Z; Zhou Z; Wang S; Ji H; Zhao D; Wang L; Chen J
Thorac Cancer; 2024 May; 15(13):1060-1071. PubMed ID: 38532562
[TBL] [Abstract][Full Text] [Related]
8. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
10. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
Liu J; Han M; Huang H
Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study.
Li Z; Xu K; Tartarone A; Santarpia M; Zhu Y; Jiang G
Transl Lung Cancer Res; 2021 Feb; 10(2):995-1006. PubMed ID: 33718038
[TBL] [Abstract][Full Text] [Related]
12. The differential diagnosis of lung precursor glandular lesions, micro-invasive adenocarcinoma, and invasive adenocarcinoma using low dose spectral computed tomography perfusion imaging.
Chen ML; Liu YL; Zhu HB; Li XT; Qi LP; Sun YS
Quant Imaging Med Surg; 2024 Jan; 14(1):814-823. PubMed ID: 38223102
[TBL] [Abstract][Full Text] [Related]
13. Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs.
Fang W; Zhang G; Yu Y; Chen H; Liu H
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35005775
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
Li Z; Cai J; Zhao Y; Cai J; Zhao X
J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
16. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Study of Artificial Intelligence-assisted Diagnosis System in Predicting the
Invasive Subtypes of Early-stage Lung Adenocarcinoma Appearing as Pulmonary Nodules].
Su Z; Mao W; Li B; Zheng Z; Yang B; Ren M; Song T; Feng H; Meng Y
Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):245-252. PubMed ID: 35477188
[TBL] [Abstract][Full Text] [Related]
18. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.
Wang H; Liu L; Yan J; Ma W; Du Y; Zhang T
Front Oncol; 2022; 12():1097816. PubMed ID: 36741689
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific nomogram models to predict the prognosis of male and female lung adenocarcinoma patients: a population-based analysis.
Wen H; Lin X; Sun D
Ann Transl Med; 2021 Nov; 9(22):1654. PubMed ID: 34988163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]